Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: A decade of discoveries, defects and disputes

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 4, Issue 2, 2003, Pages 62-73

  Andersen, Peter M ^a,b   Sims, Katherine B ^a   Xin, Winnie W ^a   Kiely, Rosemary ^a   O'Neill, Gilmore ^a   Ravits, John ^c   Pioro, Erik ^d   Harati, Yadollah ^e   Brower, Richard D ^f   Levine, Johanan S ^g   Heinicke, Hedvika U ^h   Seltzer, William ⁱ   Boss, Michael ⁱ   Brown Jr , Robert H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f Texas Tech Health Sciences Center   (United States)

^g Oates and Heinicke ^*  (United States)

^h Oates and Heinicke   (United States)

ⁱ ATHENA DIAGNOSTICS INC   (United States)

Author keywords

Amyotrophic lateral sclerosis; Gain of function; Motor neuron disease SOD1 mutation

Indexed keywords

ARGININE; ASPARTIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTEINE; GLUTAMINE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; METHIONINE; PHENYLALANINE; SERINE; THREONINE; VALINE;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL LABORATORY; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC CODE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MISSENSE MUTATION; MOTOR NEURON DISEASE; PATIENT INFORMATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; UNITED STATES;

EID: 0038446777     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/14660820310011700     Document Type: Review

References (86)

1. Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
2. Andersen PM, Morita M, Brown RH, Jr. Genetics of amyotrophic lateral sclerosis: an overview, pp223-250. In: Amyotrophic Lateral Sclerosis, edited by RH Brown Jr, V Meininger and M Swash. Martin Dunitz Publishers Ltd, London, 1999.
3. Andersen PM, Nilsson P, Keränen M-L et al. Phenotypic heterogeneity in MND-patients with Cu/Zn superoxide dismutase mutations in Scandinavia. Brain 1997; 10: 1723-1737.
4. Cudkowicz ME, McKenna-Yusen D, Asp PE et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997; 2: 210-221.
5. Shaw CE, Enayat ZE, Chioza BA et al. Mutations in all five exons of SOD1 may cause ALS. Ann Neurol 1998; 43: 390-394.
6. Boukaftane Y, Khoris J, Moulard B et al. Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis. Can J Neurol Sci 1998; 25: 192-196.
7. Jones CT, Swingler RJ, Simpson SA, Brock DJH. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290-292.
8. Jackson M, Al-Chalabi A, Enayat ZE et al. Cu/Zn superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol 1997; 42: 803-807.
9. Osler W. On heredity in progressive muscular atrophy as illustrated in the Farr family of Vermont. Arch Med 1880; 4: 316-320.
10. Garcia-Redondo A, Bustos F, Juan Y et al. Molecular analysis of the SOD1 gene in Spanish patients with sporadic or familial ALS. Muscle Nerve 2002; 26: 274-278.
11. Esteban J, Rosen DR, Bowling AC et al. Identification of two mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 997-998.
12. Nakanishi T, Kishikawa M, Miyazaki A et al. Simple and defined method to detect SOD1 mutants from patients with familial amyotrophic lateral sclerosis by mass spectrometry. J Neurosci Methods 1998; 81: 41-44.
13. Nakano R, Sato S, Inuzuka T et al. A novel mutation in Cu/Zn superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Bichem Biophys Res Com 1994; 200: 695-703.
14. Deng H-X, Hentati A, Tainer JA et al. Amyotrophic lateral sclerosis and structural defects in Cu/Zn superoxide dismutase. Science 1993; 261: 1047-1051.
15. Morita M, Aoki M, Abe K et al. A novel two-base mutation in the Cu/Zn superoxide dismutase gene associated with familial ALS in Japan. Neurosci Lett 1996; 205: 79-82.
16. Kohno S, Takahashi Y, Miyajima H et al. A novel mutation (Cys6Gly) in the Cu/Zn superoxide dismutase gene associated with rapidly progressing familial amyotrophic lateral sclerosis. Neurosci Lett 1999; 276: 135-137.
17. Hirano M, Fujii J, Nagai Y et al. A new variant Cu/Zn superoxide dismutase (Val7 Glu) deduced from lymphocyte mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 204: 572-577.
18. Bereznai B, Winkler A, Borasio GD, Gasser T. A novel SOD1 mutation in an Austrian family with amyotrophic lateral sclerosis. Neuromusc Disord 1997; 7: 113-116.
19. Kim NH, Kim HJ, Kim M, Lee KW. A novel SOD1 gene mutation in Korean patients with slowly progressive familial ALS. J Neurol Sci 2003; 206: 65-69.
20. Penco S, Schjenone A, Bordo D et al. A SOD1 gene mutation in a patient with slowly progressive familial ALS. Neurology 1999; 53: 404-406.
21. Deng H-X, Tainer JA, Mitsumoto H et al. Two novel SOD1 mutations in patients with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 1113-1116.
22. Hung W-Y, Siddique T. Am Soc Hum Genet Conf, Denver, 1998.
23. Kawamata J, Shimohama S, Takano S et al. Novel G16S (GGCAGC) mutation in the SOD1 gene in a patient with apparently sporadic young-onset amyotrophic lateral sclerosis. Hum Mutation 1997; 9: 356-358.
24. Chio A. Personal communication, 2002.
25. Jones CT, Swingler RJ, Brock DJH. Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet 1994; 3: 649-650.
26. Gellera C, Castelotti B, Riggio MC et al. Superoxide dismutase gene mutations in Italian patients with familial and sporadic amyotrophic lateral sclerosis: identification of three novel missense mutations. Neuromusc Disord 2001; 11: 404-410.
27. Aoki M, Ogasawara M, Matsubara Y et al. Mild ALS in Japan associated with a novel SOD mutation. Nat Genet 1993; 5: 323-324.
28. Enayat ZE, Orrell RW, Claus A et al. Two novel mutations in the gene for Cu/Zn superoxide dismutase in UK families with amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 1239-1240.
29. Orrell RW, Marklund SL, de Belleroche JS. Familial ALS is associated with mutations in all exons of SOD1: a novel mutation in exon 3 (Gly72Ser). J Neurol Sci 1997; 153: 46-49.
30. Segovia-Silvestre T, Andreu LA, Vives-Bauza C et al. A novel exon 3 mutation (D76V) in the SOD1 gene associated with slowly progressive ALS. Amyotrophic Lateral Sclerosis and other Motor Neuron Diseases 2003, (in press).
31. Alexander MD, Traynor , Miller N et al. "True" sporadic ALS associated with a novel SOD1 mutation. Ann Neurol 2002; 52: 680-683.
32. Aoki M, Abe K, Houi K et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn Superoxide dismutase mutation. Ann Neurol 1995; 37: 676-679.
33. Maeda T, Kurahashi K, Matsunaga M et al. On intra-familial clinical diversities of a familial amyotrophic lateral sclerosis with a point mutation of Cu/Zn superoxide dismutase (Asn86-Ser). No To Shinkei 1997; 49: 847-851.
34. Jacobsson J, Jonsson A, Andersen PM et al. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without Cu/Zn superoxide dismutase mutations. Brain 2001; 124: 1461-1466.
35. Andersen PM, Nilsson P, Ala-Hurula V et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in Cu/Zn superoxide dismutase. Nat Genet 1995; 10: 61-66.
36. Morita M, Abe K, Takahashi M et al. A novel mutation Asp90Val in the SOD1 gene associated with Japanese familial ALS. Eur J Neurol 1998; 5: 389-392.
37. Elshafey A, Lanyon WG, Connor JM. Identification of a new missense mutation in exon 4 of the Cu/Zn superoxide dismutase (SOD1) gene in a family with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 2: 363-364.
38. Kawata A, Kato S, Hayashi H, Hirai S. Prominent sensory and autonomic disturbances in familial amyotrophic lateral sclerosis with a Gly93Ser mutation in the SOD1 gene. J Neurol Sci 1997; 153: 82-85.
39. Hosler BA, Nicholson GA, Sapp PC et al. Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. Neuromusc Disord 1996; 6: 361-366.
40. Traynor BJ, Corr B, Frost E et al. Cu/Zn superoxide dismutase 1 and ALS: a population analysis. J Neurology 1999; 246 Suppl. 1: S60.
41. Hand CK, Mayeux-Portas V, Khoris J et al. Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann Neurol 2001; 49: 267-271.
42. Siddique T, Deng H-X. Genetics of ALS. Hum Mol Genet 1996; 5: 1465-1470.
43. Yulug IG, Katsanis N, de Belleroche J et al. An improved protocol for the analysis of SOD1 mutations, and a new mutation in exon 4. Hum Mol Genet 1995; 4: 1101-1104.
44. Jones CT, Shaw PJ, Chari G, Brock DJH. Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cellul Probes 1994; 8: 329-330.
45. Abe K, Aoki M, Ikeda M et al. Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J Neurol Sci 1996; 136: 108-116.
46. Andersen PM, personal communication, 2000.
47. Orrell RW, Jabgood JJ, Shepherd DI et al. A novel mutation of SOD1 (Gly108Val) in familial amyotrophic lateral sclerosis. Eur J Neurol 1997; 4: 48-51.
48. Kostrzewa M, Burck-Lehmann U, Müller U. Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn superoxide dismutase-1 gene. Hum Mol Genet 1994; 3: 2261-2262.
49. Shimizu T, Kawata A, Kato S et al. Autonomic failure in ALS with novel SOD1 gene mutation. Neurology 2000; 54: 1534-1537.
50. Pramatarova A, Goto J, Nanba E et al. A two basepair deletion in the SOD1 gene causes familial amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 2061-2062.
51. Murakami T, Warita H, Hayashi T et al. A novel SOD1 gene mutation in familial ALS with low penetrance in females. J Neurol Sci 2001; 189: 45-47.
52. Zu JS, Deng H-X, Lo TP et al. Exon 5 encoded domain is not required for the toxic function of mutant SOD1 but essential for the dismutase activity: identification and characterization of two new SOD1 mutations associated with familial amyotrophic lateral sclerosis. Neurogenetics 1997; 1: 65-71.
53. Hansen C, Gredal O, Werdelin L et al. Novel 4-bp insertion in the Cu/Zn superoxide dismutase (SOD1) gene associated with familial amyotrophic lateral sclerosis. Hum Mutation 1998 Suppl. 1: S327-8.
54. Orrell RW, Habgood JJ, Gardiner I et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for Cu/Zn superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 1997; 48: 746-751.
55. Watanabe M, Aoki M, Abe K et al. A novel missense point mutation (S134N) of the Cu/Zn superoxide dismutase gene in a patient with familial motor neuron disease. Hum Mutation 1997; 9: 69-71.
56. Jafari-Schluep HF, Khoris J, Mayeux-Portas V et al. Les anomalies du gène superoxyde dismutase 1 dans la sclérose latérale amyotrophique familiale: corrélations phénotype-génotype et implications pratiques. Rev Neurol 2003. (in press).
57. Pramatarova A, Figlewicz DA, Krizus A et al. Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet 1995; 56: 592-596.
58. Naini A, Musumeci O, Hayes L, et al. Identification of a novel mutation in Cu/Zn SOD gene associated with familial ALS. J Neurol Sci 2002; 198: 17-19.
59. Sapp PC, Rosen DR, Hosler BA et al. Identification of three novel mutations in the gene for Cu/Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscular Disord 1995; 5: 353-357.
60. DP Keckarevic. Personal communication, 2001.
61. Ikeda M, Abe K, Aoki M et al. A novel point mutation in the Cu/Zn superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 491-492.
62. Kostrzewa M, Damian MS, Müller U. Superoxide dismutase 1: identification of a novel mutation in a case of familial amyotrophic lateral sclerosis. Hum Genet 1996; 98: 48-50.
63. Calder VL, Domigan NM, George PM et al. Superoxide dismutase (Glu100Gly) in a family with inherited motor neuron disease: detection of mutant superoxide dismutase activity and the presence of heterodimers. Neurosci Lett 1995; 189: 143-146.
64. Andersen PM, Forsgren L, Binzer M et al. Autosomal recessive adult-onset ALS associated with homozygosity for Asp90Ala Cu/Zn superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996; 119: 1153-1172.
65. Vulpian A. Maladies du système nerveux (moelle épinière). Vol 2, chapter 23. Paris: Octave Doin, 1886: 436.
66. Andersen PM, Spitsyn VA, Makarov SV et al. The geographic and ethnic distribution of the D90A Cu/Zn SOD mutation in the Russian Federation. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2: 63-69.
67. Parton MJ, Broom W, Andersen PM et al. D90A-SOD1 mediated amyotrophic lateral Sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifer in the recessive haplotype. Human Mutation 2002; 20: 473.
68. Pardo CA, Xu Z, Borchelt DR et al. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 1995; 92: 954-958.
69. Cleveland DW, Rothstein JD. From Charcot to Lougehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001; 2: 806-819.
70. Yim HS, Kang JH, Chock PB et al. A familial amyotrophic lateral sclerosis-associated A4V Cu/Zn superoxide dismutase mutant has a lower Km for hydrogen peroxide. Correlation between clinical severity and the Km value. J Biol Chem 1997; 272: 8861-8863.
71. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynitrite. Nature 1993; 364: 584.
72. Ferri A, Gabbianelli R, Casciati A et al. Oxidative inactivation of calcineurin by Cu/Zn superoxide dismutase G93A, a mutant typical of familial amyotrophic lateral sclerosis. J Neurochem 2001; 79: 531-538.
73. Wong PC, Pardo CA, Borchelt DR et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105-1116.
74. Kunst CB, Mezey E, Brownstein MJ, Patterson D. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet 1997; 15: 91-94.
75. Okado-Matsumoto A, Fridovich I. Amyotrophic lateral sclerosis: a proposed mechanism. Proc Natl Acad Sci USA 2002; 99: 9010-9014.
76. Durham HD, Roy J, Deng L, Figlewicz DA. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol 1997; 56: 523-530.
77. Lindberg MJ, Tibell L, Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apostate. Proc Natl Acad Sci USA 2002; 99: 16607-16612.
78. Tiwari A, Hayward LJ. Familial ALS mutants of Cu/Zn superoxide dismutase are susceptible to disulfide reduction. J Biol Chem 2003; 278: 5984-5992.
79. Subramaniam JR, Lyons WE, Liu J et al. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat Neurosci 2002; 5: 301-307.
80. Malaspina A, Kaushik N, Belleroche J de. Differential expression of 14 genes in ALS spinal cord detected using gridded cDNA arrays. J Neurochemistry 2001; 77: 132-145.
81. Ogawa Y, Kosaka H, Nakanishi T et al. Stability of mutant superoxide dismutase1 associated with familial ALS determines the manner of copper release and induction of thioredoxin in erythrocytes. Biochem Biophys Res Commun 1997; 241: 251-257.
82. Hadano S, Hand CK, Osuga H et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001; 29: 166-173.
83. Yang Y, Hentati A, Deng HX et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001; 29: 160-165.
84. Gudesblatt M, Ludman MD, Cohen JA et al. Hexosaminidase A activity and amyotrophic lateral sclerosis. Muscle Nerve 1988; 11: 227-230.
85. Hayward C, Colville S, Swingler RJ, Brock DJ. Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology 1999; 52: 1899-1901.
86. van Landeghem GF, Tabatabie P, Beckman G et al. Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease. Eur J Neurol 1999; 6: 639-644.